The impacts of the national volume-based procurement policy on the chronic disease medication market in China’s public hospitals: a case study of medications for diabetes
Abstract Background The exorbitant cost of chronic disease medications poses a shared challenge for healthcare systems worldwide. China introduced the national volume-based procurement (NVBP) policy in 2018, aiming to leverage market mechanisms to lower medication costs and rationalize prescription...
Сохранить в:
| Главные авторы: | , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMC
2025-10-01
|
| Серии: | BMC Health Services Research |
| Предметы: | |
| Online-ссылка: | https://doi.org/10.1186/s12913-025-13449-3 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|